nach oben

Annals of Hematology

Erschienen in:

01.07.2018 | Letter to the Editor

Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China

verfasst von: Lan-Lan Meng, Shi-Min Yuan, Chao-Feng Tu, Ge Lin, Guang-Xiu Lu, Yue-Qiu Tan

Erschienen in: Annals of Hematology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear editor, …

Gallagher PG, Forget BG (1998) Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 24(4):539–543. https://doi.org/10.1006/bcmd.1998.0217 CrossRefPubMed

Perrotta S, Gallagher PG, Mohandas N (2008) Hereditary spherocytosis. Lancet 372(9647):1411–1426. https://doi.org/10.1016/S0140-6736(08)61588-3 CrossRefPubMed

Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in H (2012) Guidelines for the diagnosis and management of hereditary spherocytosis—2011 update. Br J Haematol 156(1):37–49. https://doi.org/10.1111/j.1365-2141.2011.08921.x CrossRefPubMed

King MJ, Garcon L, Hoyer JD, Iolascon A, Picard V, Stewart G, Bianchi P, Lee SH, Zanella A, International Council for Standardization in H (2015) ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 37(3):304–325. https://doi.org/10.1111/ijlh.12335 CrossRefPubMed

Becker PS, Tse WT, Lux SE, Forget BG (1993) Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Investig 92(2):612–616. https://doi.org/10.1172/JCI116628 CrossRefPubMed

Iwamoto S, Kajii E, Omi T, Kamesaki T, Akifuji Y, Ikemoto S (1993) Point mutation in the band 4.2 gene associated with autosomal recessively inherited erythrocyte band 4.2 deficiency. Eur J Haematol 50(5):286–291CrossRefPubMed

Christensen RD, Yaish HM, Nussenzveig RH, Agarwal AM (2016) Siblings with severe pyruvate kinase deficiency and a complex genotype. Am J Med Genet A 170(9):2449–2452. https://doi.org/10.1002/ajmg.a.37828 CrossRefPubMed

Eber S, Lux SE (2004) Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 41(2):118–141CrossRefPubMed

Becker PS, Morrow JS, Lux SE (1987) Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding. J Clin Investig 80(2):557–565. https://doi.org/10.1172/JCI113104 CrossRefPubMed

10.

Park J, Jeong DC, Yoo J, Jang W, Chae H, Kim J, Kwon A, Choi H, Lee JW, Chung NG, Kim M, Kim Y (2016) Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis. Clin Genet 90(1):69–78. https://doi.org/10.1111/cge.12749 CrossRefPubMed

11.

Silva AL, Romao L (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? FEBS Lett 583(3):499–505. https://doi.org/10.1016/j.febslet.2008.12.058 CrossRefPubMed

12.

Eber SW, Morris SA, Schroter W, Gratzer WB (1988) Interactions of spectrin in hereditary elliptocytes containing truncated spectrin beta-chains. J Clin Invest 81(2):523–530. https://doi.org/10.1172/JCI113350 CrossRefPubMedPubMedCentral

13.

Gallagher PG, Forget BG (1996) Hematologically important mutations: spectrin variants in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis 22(3):254–258. https://doi.org/10.1006/bcmd.1996.0105 CrossRefPubMed

14.

Hanspal M, Palek J (1987) Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors. J Cell Biol 105(3):1417–1424CrossRefPubMed

15.

Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, Garcia-Orad A, Tejada MI, Garcia-Ruiz JC, Fidalgo T, Bento C, Manco L, Ribeiro ML (2016) Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol 38(6):629–638. https://doi.org/10.1111/ijlh.12551 CrossRefPubMed

16.

Schafer A, Fraccarollo D, Widder J, Eigenthaler M, Ertl G, Bauersachs J (2009) Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer. Eur J Heart Fail 11(4):336–341. https://doi.org/10.1093/eurjhf/hfp005 CrossRefPubMed

17.

Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER (2013) The next-generation sequencing revolution and its impact on genomics. Cell 155(1):27–38. https://doi.org/10.1016/j.cell.2013.09.006 CrossRefPubMedPubMedCentral

Titel: Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China
verfasst von: Lan-Lan Meng
Shi-Min Yuan
Chao-Feng Tu
Ge Lin
Guang-Xiu Lu
Yue-Qiu Tan
Publikationsdatum: 01.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 1/2019
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-018-3417-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality

Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma

Hemophagocytic syndrome in patients living with HIV: a retrospective study

Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor

Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China

Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin